| Literature DB >> 29068396 |
Xiangjun Kong1, Dongmei Liu2, Xiaofang Liao3, Jie Zheng4, Yong Diao5, Yiding Liu6, Ruiyang Zhou7.
Abstract
In this study, the tetrad stage of microspore development in a new cotton (Gossypium barbadense L.) cytoplasmic male sterility (CMS) line, H276A, was identified using paraffin sections at the abortion stage. To explore the molecular mechanism underlying CMS in cotton, a comparative transcriptome analysis between the CMS line H276A and its maintainer line H276B at the tetrad stage was conducted using an Illumina HiSeq 4000 platform. The comparison of H276A with H276B revealed a total of 64,675 genes, which consisted of 59,255 known and 5420 novel genes. An analysis of the two libraries with a given threshold yielded a total of 3603 differentially expressed genes (DEGs), which included 1363 up- and 2240 down-regulated genes. Gene Ontology (GO) annotation showed that 2171 DEGs were distributed into 38 categories, and a Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis showed that 2683 DEGs were classified into 127 groups. Thirteen DEGs were randomly selected and detected by quantitative reverse-transcribed PCR (qRT-PCR), and the results indicated that the transcriptome sequencing results were reliable. The bioinformatic analysis results in conjunction with previously reported data revealed key DEGs that might be associated with the male sterility features of H276A. Our results provide a comprehensive foundation for understanding anther development and will accelerate the study of the molecular mechanisms of CMS in cotton.Entities:
Keywords: cotton (Gossypium barbadense L.); cytoplasmic male sterility (CMS); differentially expressed genes (DEGs); microspore development; transcriptome
Mesh:
Year: 2017 PMID: 29068396 PMCID: PMC5713210 DOI: 10.3390/ijms18112240
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Phenotype of the floral buds of the cytoplasmic male sterility (CMS) line H276A and its maintainer H276B: (A): CMS line H276A; (B): Maintainer line H276B. Notes: PMC, pollen mother cell stage; Td, tetrad stage; early Uni, early uninucleate; late Uni, late uninucleate; MP, mature pollen stage.
Figure 2Comparative analysis of anther development between H276A (A1–A5) and H276B (B1–B5). Notes: Bar = 50 μm for all of the stage. PMC, pollen mother cell; Ep, epidermis; En, endothecium; ML, middle layer; T, tapetum; Ms, microspore; MP, mature pollen.
Figure 3Comparison of gene expression levels between H276A and H276B according to the DEseq2 method.
Transcriptome sequencing data quality and genome mapping.
| Sample | H276A-1 | H276A-2 | H276A-3 | H276B-1 | H276B-2 | H276B-3 |
|---|---|---|---|---|---|---|
| Total Raw Reads (Mb) | 50.42 | 53.42 | 51.82 | 51.81 | 51.82 | 51.82 |
| Total Clean Reads (Mb) | 40.38 | 44.48 | 44.73 | 44.58 | 44.25 | 44.37 |
| Clean Reads Q20 (%) | 98.06 | 98.01 | 98.39 | 98.38 | 98.39 | 98.34 |
| Total Mapping Ratio (%) | 73.34 | 74.20 | 75.20 | 76.04 | 75.60 | 76.18 |
| Total Gene Number | 57,228 | 57,777 | 57,428 | 56,938 | 56,929 | 56,629 |
| Total Transcript Number | 86,162 | 87,603 | 85,063 | 85,039 | 84,961 | 84,434 |
| Novel Transcript Number | 20,514 | 20,952 | 20,288 | 20,580 | 20,554 | 20,474 |
Figure 4Distribution of the differentially expressed genes (DEGs) between H276A and H276B identified using different fold-change thresholds.
Figure 5Gene ontology classification of DEGs in the H276A vs. H276B library.
Statistical enrichment analysis of Kyoto Encyclopedia of Genes and Genomes (KEGG) metabolic pathways (p ≤ 0.05, Q ≤ 0.05).
| Pathway | Pathway ID | Genes with Pathway Annotation | |||
|---|---|---|---|---|---|
| DEGs (2683) | All Genes (56,363) | ||||
| Carbohydrate Metabolism | |||||
| Ascorbate and aldarate metabolism | ko00053 | 87 (3.24%) | 747 (1.33%) | 2.1883346 × 10−14 | 2.772849 × 10−12 |
| Amino sugar and nucleotide sugar metabolism | Ko00520 | 132 (4.92%) | 1789 (3.17%) | 5.144044 × 10−7 | 1.306587 × 10−5 |
| Galactose metabolism | Ko00052 | 93 (3.47%) | 1264 (2.24%) | 2.652517 × 10−5 | 3.142800 × 10−4 |
| Pentose and glucuronate interconversions | Ko00040 | 119 (4.44%) | 1711 (3.04%) | 2.72211 × 10−5 | 3.142800 × 10−4 |
| Fructose and mannose metabolism | Ko00051 | 48 (1.79%) | 623 (1.11%) | 0.0008306261 | 6.203606 × 10−3 |
| Pentose phosphate pathway | Ko00030 | 44 (1.64%) | 562 (1%) | 0.0009706133 | 6.487784 × 10−3 |
| Glycolysis/gluconeogenesis | Ko00010 | 62 (2.31%) | 894 (1.59%) | 0.00222321 | 1.344513 × 10−2 |
| Global and Overview Map | |||||
| Metabolic pathways | ko01100 | 822 (30.64%) | 14,040 (24.91%) | 3.498244 × 10−12 | 2.221385 × 10−10 |
| Biosynthesis of secondary metabolites | Ko01110 | 464 (17.29%) | 8032 (14.25) | 3.713275 × 10−6 | 5.239844 × 10−5 |
| Biosynthesis of Other Secondary Metabolites | |||||
| Flavonoid biosynthesis | Ko00941 | 35 (1.3%) | 266 (0.47%) | 6.13195 × 10−8 | 2.595859 × 10−6 |
| Stilbenoid, diarylheptanoid and gingerol biosynthesis | Ko00945 | 31 (1.16%) | 240 (0.43%) | 5.103317 × 10−7 | 1.306587 × 10−5 |
| Flavone and flavonol biosynthesis | Ko00944 | 12 (0.45%) | 105 (0.19%) | 0.004277302 | 2.263406 × 10−2 |
| Phenylpropanoid biosynthesis | Ko00940 | 91(3.39%) | 1497 (2.66%) | 0.01086005 | 4.755953 × 10−2 |
| Metabolism of Terpenoids and Polyketides | |||||
| Zeatin biosynthesis | Ko00908 | 24 (0.89%) | 162 (0.29%) | 8.181436 × 10−7 | 1.731737 × 10−5 |
| Limonene and pinene degradation | Ko00903 | 24 (0.89%) | 210 (0.37%) | 7.083635 × 10−5 | 7.496847 × 10−4 |
| Carotenoid biosynthesis | Ko00906 | 21 (0.78%) | 244 (0.43%) | 0.006774023 | 3.308850 × 10−2 |
| Transcription | |||||
| RNA polymerase | Ko03020 | 79 (2.94%) | 962 (1.71%) | 2.302535 × 10−6 | 3.878907 × 10−5 |
| Energy Metabolism | |||||
| Nitrogen metabolism | Ko00910 | 22 (0.82%) | 149 (0.26%) | 2.443406 × 10−6 | 3.878907 × 10−5 |
| Photosynthesis | Ko00195 | 22 (0.82%) | 213 (0.38) | 0.0005760129 | 4.572102 × 10−3 |
| Lipid Metabolism | |||||
| Sphingolipid metabolism | Ko00600 | 33 (1.23%) | 338 (0.6%) | 8.44879 × 10−5 | 8.543074 × 10−4 |
| α-Linolenic acid metabolism | Ko00592 | 27 (1.01%) | 272 (0.48%) | 0.0002803392 | 2.543077 × 10−3 |
| Glycerolipid metabolism | Ko00561 | 65 (2.42%) | 895 (1.59%) | 0.0005644657 | 4.572102 × 10−3 |
| Amino Acid Metabolism | |||||
| Tryptophan metabolism | Ko00380 | 26 (0.97%) | 278 (0.49%) | 0.0008792512 | 6.203606 × 10−3 |
| Metabolism of Other Amino Acids | |||||
| Taurine and hypotaurine metabolism | Ko00430 | 6 (0.22%) | 30 (0.05%) | 0.002561534 | 1.478704 × 10−2 |
| Glycan Biosynthesis and Metabolism | |||||
| Glycosaminoglycan degradation | Ko00531 | 23 (0.86%) | 251 (0.45%) | 0.002192842 | 1.344513 × 10−2 |
| Other glycan degradation | Ko00551 | 42 (1.57%) | 562 (1%) | 0.002931596 | 1.618751 × 10−2 |
| Glycosphingolipid biosynthesis (ganglio series) | Ko00604 | 16 (0.6%) | 164 (0.29%) | 0.005312663 | 2.698833 × 10−2 |
| Glycosphingolipid biosynthesis (globo series) | Ko00603 | 8 (0.3%) | 61 (0.11%) | 0.00811891 | 3.818895 × 10−2 |
| Transport and Catabolism | |||||
| Regulation of autophagy | Ko04140 | 34 (1.27%) | 462 (0.82%) | 0.008579786 | 3.891546 × 10−2 |
qRT-PCR confirmation of the expression profiles of select genes.
| Gene ID | Protein Identity | Fold Change | |
|---|---|---|---|
| RNA-Seq | qRT-PCR | ||
| LOC107957220 | Glycine-rich cell wall structural protein-like | 4.92 | 5.02 |
| LOC107903993 | PPR protein At2g01860-like | 2.81 | 0.70 |
| LOC107893809 | MADS-box CMB1 | 2.81 | 1.65 |
| LOC107928908 | Hyoscyamine 6-dioxygenase-like | 2.73 | 2.71 |
| LOC107940910 | Ethylene responsive element binding protein 3 | 2.59 | 2.63 |
| LOC107916224 | Cell wall/vacuolar inhibitor of fructosidase 1-like | 1.96 | 2.11 |
| LOC107919764 | Transcription factor MYB86 | −3.21 | −3.60 |
| LOC107908692 | Pentatricopeptide repeat-containing protein At3g11460 | −3.38 | −4.38 |
| LOC107940452 | Flavonol synthase/flavanone 3-hydroxylase-like | −3.86 | −1.19 |
| LOC107941000 | Tetraketide α-pyrone reductase 1 | −3.94 | −3.50 |
| LOC107961143 | Anther-specific protein LAT52 | −4.03 | −2.74 |
| LOC107945055 | Chalcone synthase | −5.15 | −5.72 |
| LOC107900663 | Bifunctional pinoresinol-lariciresinol reductase 2 | −5.67 | −3.43 |
Fold change refers to the expression in the CMS line compared with that in the maintainer line. A negative value indicates down-regulated expression in the CMS line.